What Happened? A number of stocks jumped in the afternoon session after sentiment improved as President Trump indicated that ...

About Health CatalystHealth Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, ...

Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a ...

Health Catalyst, Inc. (NASDAQ:HCAT) is one of the best Robinhood stocks on this list. TheFly reported on March 18 that Wells ...

Health Catalyst made news on a couple different fronts this week, as it announced its plans to acquire Yakima, Washington-based Vitalware and entered a long-term strategic-analytics partnership with ...

The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID ...

For a detailed discussion of the risk factors that could affect Health Catalyst's actual results, please refer to the risk factors identified in Health Catalyst's SEC reports, including, but not ...

Health Catalyst has acquired Health Care DataWorks, a company with roots in Ohio State University, and one that works on improving patient outcomes much like Health Catalyst does. The deal means that ...

Health Catalyst CEO Dan Burton will step down from his role in June 2026 to pursue volunteer service opportunities. Mr. Burton has led the data analytics company for more than 14 years, according to ...

Shares of healthcare data analytics company Health Catalyst (NASDAQ:HCAT) fell 4.2% in the afternoon session after Wells Fargo downgraded the company's stock to Equal Weight from Overweight and ...

Meet the company: Health Catalyst is a data warehousing, analytics and outcomes improvement company that helps healthcare organizations improve clinical, financial and operational outcomes required to ...

TheFly reported on March 18 that Wells Fargo lowered its rating on HCAT to Equal Weight from Overweight and slashed its price target from $5 to $1. According to the firm, recent sales and strategic ...